StockWatch
·
Biotechnology: Pharmaceutical Preparations
InvestmentApr 30, 2026, 05:02 PM

PLRZ Raises $17.0M in Private Placement; Details Recent Offerings

AI Summary

Polyrizon Ltd. detailed its indemnification policies for directors and officers under Israeli law, noting the SEC's stance on enforceability for Securities Act liabilities. The company also reported several recent securities sales, including a significant private placement on March 31, 2025, which raised approximately $17.0 million. Further capital was raised through registered direct offerings in December 2025 and April 2026, along with a concurrent private placement in April 2026.

Key Highlights

  • March 31, 2025: Raised approximately $17.0M in a private placement of Ordinary and Pre-Funded Units.
  • March 31, 2025: Issued 2,245,834 Ordinary Units and 33,170,833 Pre-Funded Units to institutional investors.
  • December 5, 2025: Raised approximately $4.97M from a registered direct offering of 552,269 Ordinary Shares at $9.00/share.
  • April 7, 2026: Completed a registered direct offering of 87,777 Ordinary Shares and 190,000 pre-funded warrants.
  • April 7, 2026: Issued 111,111 PIPE Pre-Funded Warrants and 388,888 Ordinary Share Warrants in a concurrent private placement.
  • Company provides indemnification and insurance for office holders under Israeli Companies Law.
  • SEC deems indemnification for Securities Act liabilities against public policy and unenforceable.